ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Osocimab Biosimilar - Anti-Factor XI Antibody - Low endotoxin, Azide free (A323639)

Recombinant human monoclonal antibody to Factor XI for ELISA, FACS, Kinetics (BLI), Kinetics (SPR) and Functional Assay.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Osocimab Biosimilar - Anti-Factor XI Antibody - Low endotoxin, Azide free
Description
Recombinant human monoclonal antibody to Factor XI.
Applications
ELISA, FACS, Kinetics (BLI), Kinetics (SPR), Functional Assay
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145.5 kDa.
Purity
> 90% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
Coagulation factor XI, F11, FXI, Plasma thromboplastin antecedent, PTA
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Osocimab Biosimilar - Anti-Factor XI Antibody - Low endotoxin, Azide free (A323639)? Please let us know so that we can list the citation on this page.

Alternative products to Osocimab Biosimilar - Anti-Factor XI Antibody - Low endotoxin, Azide free (A323639)

Proteins predicted to interact with Factor XI

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.8% Relevancy Score
96.9% Relevancy Score
96.7% Relevancy Score
96.6% Relevancy Score
95.4% Relevancy Score
95.4% Relevancy Score
92.3% Relevancy Score
87.3% Relevancy Score
79.2% Relevancy Score